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Patients with stable cownary anery disease frequently have 
episodes of asymptomatic ischemia during routine ambula- 
tory aaivilies. Several studies (l-3) have shown that the 
presence of such episcdes is aswxiated with an increased 
incidence of subsequent adverse cardiac events. Although 
the independent prognostic significance of these episodes 
has been suggested (4) but not confirmed. idenlification of 
Readis. With &xko there w no care I&x 
fmqwiwy of ischpaic wImdes by amkulalwy ECG mc+dlerIw, 
such patients with ambulatory asymptomatic ischeinia may 
be of value to assess prognosis and to assist with clinical 
management (5). 
Some studies have suggesred that !he presence of asymp- 
tomatic ischemia can be inferred from clinical symptoms and 
conventional measures of ischemia such as exercise test 
perfomunce (6.7). However, qcxts (S-10) have indicated 
that the severity of asymptomatic ischemia bears litlk reia- 
tian lo exercise performance and anginal symptoms. In a 
similar manner. although the goal of antianginal therapy is to 
reduce anginal symptoms. it is unknown whether such 
therapy should also be directed toward the other manifesta- 
tions of ischemia such as exercise test performance and 
ambulatory asymDtomatic ischcmia and whether anti- 
ischemic &i&y I’s similar among the different manifesta- 
tions of ischemia (5). 
The Angina and Silent Irchemia Sfudy (ASIS) data base 
provides a unique resource to investigate the relative and- 
ischemic etficxy of different drug regimens on different 
manifestations of ischemia. Accordingly, the purposes of 
this study were I) to compare the auti-ischemic efficacy of 
three single-agent antiauginal drugs (sustained release pro- 
pranolol, sustained release diltiazem aad nifedipine) on three 
clinical manifestations of coronary diseasespecifically, an- 
gina pectwis, exercise test perfom~ance and episodes of 
ischemia during routine ambulatory outpatient activities; 
and 2) to determine whether the degree of anti-iscbemic 
et?icacy with respect to one manifestation of &hernia was 
similar to the etfcacv with resoect to other manifestations of _ . 
ischemiaor whether each measure of ischemiaresponded to 
treatment in an independent manner. 
Methods 
Study design. Patients studied were those from the pre- 
viously reported Angina and Silent Ischemia Study (II), 
which was a randomized, double-blind, placebo-controlled 
crossover study using sustained release propranolol, sus- 
tained release diltiazem, nifedipine and placebo as single- 
aged therapy for stable coronary disease. lnfomwd consent 
was obtained from all patients, and the study was approved 
by the Institutional Review Board at each of the participating 
centers (see Appendix). The methods ofthis study have been 
published in detail (1 I) and are briefly reviewed here. Pa- 
tients were recruiled for study participation if they met the 
following criteria: I) stable angina pectoris without a major 
change in angina1 pattern for the preceding 2 months; 
2) positive exercise test characterized by both angina aad al 
least I mm of reversible ST segment depression; 3) ability to 
complete stage I of the standard Bruce exercise protocol 
with a positive ischemic response by stage 3 or less; 
4) coronary disease documented either by prior angiography 
showing at least one major coronary artery or irs branches 
with 150% reduction in lumen diameter, prior mywardial 
infarction or a reversible defect evident on stress- 
recafusion thallium imaainfi: 5) at least six euiwdes of 
ambulatory ischemia in ai8-h pbod, of which ai least two 
were asymptomatic. 
Patients were excluded from the study if any of the 
following were present: I) myocardial inf&ion o; cardiac 
sumery within 3 months: 2) conaestive heart failure of New 
York Heart Associarion class Ii1 or more. or uncontrolled 
hypertension (blood pressure ~180/105 mm Hg): 3) ST 
Segment deviation ?I mm at rest or in response to hypw 
ventilation or positional changes; 4) presence of conditions 
known to preclude accurate interpretation of ST segment 
deviation (conduction delay, left ventricular hypertrophy 
and digitalis administration, for example); >I atriovenbicular 
block, sick sinus syndrome, ventricular pre-excitation or 
electronic pacemaker; 6) contraindication to any study med- 
ications; 7) presence of marked coronary artery vasospasm 
(Prinzmetal’s angina); 8) sigaificant major systemic diseases; 
and 9) child-bearing potential. 
Patients who met entry criteria were withdrawn from all 
anti-ischemic medications except ior nitroglycerin taken 
sublingually, as needed for relief of chest pain. They were 
then given placebo in a single-blind fashion for 1 to 2 weeks, 
after which a screening exercise test was performed. If the 
exercise test was positive for the development of both angina 
and horizontal or downslooina ST seament deoression 
SLO mm, a screening 48-h &bulatory ~lectroc~diogram 
(ECG) recording was obtained. If the ambulatory ECG 
indicated six or more episodes of ischemia, at least two of 
which were asymptomatic, the patient was randomized and 
entered the first of four double-bliml treatment chases. each 
lasting 2 weeks. 
During the Is1 3 days ofeach treatment phase, the dosage 
of each study medication was increased to the hiahest 
tolerated level without unacceptable side effects. Patients 
were randomized according to a balanced scheme to receive 
either sustained release propranolol, sustained release dilt- 
iazem, nifedipiae or placebo. The mean dosages of study 
medication achieved were propranolol, 293 rag in two di- 
vided doses: diltiazem, 350 mg in two divided doses aad 
nifedisine. 19 mg in three divided doses. For each reaimen, 
the m&imal tol&tcd dose was continued until the&d of 
the Z-week treatment phase, when an exerciSe treadmill test 
and a 48-h ambulatory ECG wrre performed. Throughout 
each treatment period the patient maintaimd a diary for 
recording the frequency of anginal episodes and the number 
of nitroglycerin tablets consumed. After completion of each 
treatment phase, the next randomly assigned medication was 
begun in identical fashion. 
AmMatary RCG ma&ring. Ambulatory 48-h EC&i re- 
eordings were performed using Applied Cardiac Systems 
AM Cassette Recorders with m&id leads V, aad aVF. 
Recordings were analyzed in the central core laboratory with 
a CardioData Mk 4 playback system with o&tied software, 
as previously described (II). The technician and physician 
reviewing the data were unaware of treatment assignment. 
An ischemic episode was defined as transient ST segment 
depression ~1.0 mm lasting at least I min. The onset was 
defined as the time at which the ST segment became de- 
pressed by 0.5 mm before reaching al&mm depression. 
The offset was defined as the time after the maximal depres- 
sion when the ST segment was returning to the bs tini and 
reached a level of 0.5-mm depression. A new ischemic 
episode could not be identified unlil the ST segment had 
returned to baseline and remained stable for at least 5 min. 
lschemic episodes were correlated with diary entries made 
by patients to determine whether angina was present or 
absent. 
Exercise twdmitt testing. Exercise tests were performed 
according to the standard Bruce protocol and we& symptom 
limited. Patients underwent treadmill testina aoomximately . . . 
2 h after the last medication dose. Interpretation of EC& 
was performed in the exercise treadmill test core laboratory 
by a physician who was unaware of treatment assignment. 
Study end painta. Among the data collected during the 
original study, several elements were selected for the 
present analysis. These included two measu~emeots irom 
each of three categories of ischemic manifestations. An&d 
episodes were quantified as both the total number of epi- 
sodes/week and the total number of nitroglycerin tablets 
consometiweek based on the entries made by patients in 
diaries. Exercise performance, as determined by the stan- 
dard Bruce treadmill test. was measured as both the total 
duration of exercise (measured in minutes) and the time lo 
I-mm ST segment depression (measured in minutes). Mea- 
surement of ischemic episodes was based on data derived 
from the 4&h ambulatory ECG. and included both the total 
number of ischemic eDisodesR4 h and the total duration of 
ischemiaQ4 h (mea&d in minutes). Ninety-four percent of 
all episodes of ambulatory ischemia were asymptomatic 
during the double-blind treatment Dhase; the symutomatic 
episodes (6% of the total number bf episodes). w&e corn- 
bined with the asymptomatic episodes for analysis. 
Stalidkal asmlysis. Foreach end point andforeach ofthe 
active agents, variables were expressed as the difference 
between a particular drug and placebo. Correlation analysis 
was then performed using the nonparametric Spearman 
method for responses to each of the agents aad for each 
tneaawe of &hernia. 
Results 
St&r ~atkels. A arooD of 194 oatients from eight insti- 
tutions w&e screenedfor ~&tici&oo in the stud; A total 
of 63 eligible patients received randomized treatment; of 
these, 7 discontinued pxlicipation after compkting fewer 
than two double-blind treatment periods (I patient because 
of death. 5 Datients because of the deVeloD”Rat of unstable 
angina or a&e myocardial infarction and-1 patient because 
of an orthopedic problem) and were therefore not available 
for analysis of comtmrative etTicacy. Fifty-six patients com- 
pleted two or more double-blind treatment periods, but six 
patients did not correctly complete all four treatment peri- 
ods: one patient because of worsening angina, one patient 
because of dizziness and four patients because of failure to 
adhere to the protocol despite completion of the study. of 
the latter four, one used a concomitant proscribed medica- 
tion and three did not undergo ambulatory ECG monitoring 
during a treatment phase. A total of 50 patients correctly 
completed all four treatment phases and were included in the 
present analysis: their characteristics are shown in Table 1. 
The outcome of these patients in terms of ambulatory 
ischemk episodes, an!&l episodes and exercise test per- 
formance on each of the study regimens has ‘leen previously 
rep0lIe.d (II). 
Pmdwvev~ofexmcisetestpr6wmplmandnnginal 
sympMsfixtbepresawofmymptomatkk&mh.To 
detent&e whether the extent of ambulatory ischemia could 
be predicted from meawes of anginaI symptoms or exerrise 
perfommce, correlation analysis was performed on data 
from the SO patients, focusing only on the placebo treatment 
phase. As shown in Table 2, there was no relation among the 
different methods of assessing the presence or severity of 
ischemia. A stmng relation was demonstsated when two 
similar measures were compared within each category: 
during ambulatory ECG monitoring, the Dumber of ischemic 
episode*24 h was closely con-&&d with the doration of 
ischemial24 h: the number of ansinaI e&&s/week was 
closely correlated with the numb& of niiroglycetin tablets 
consumed/week; and the total duration of e?.&se during 
the exercise test was closely correlated with exercise dura- 
tion at the onset of I-mm ST segment depression. 
A&wssmcnt ofdilfumt~rcsdkcbcmi& The coacor- 
dance of measures of ischemia within a testing method (that 
is. ambulatory ECG monitoring, angina diary and exercise 
treadmill test) observed during placebo therapy was also 
examined duringtherapy with eachof the three active agents 
(Table 3). During each drug phase there was a close cotx- 
lation between ihe two m&&es of ischemia within each 
testiaa method. Because of the similar tindinas of the two 
mea&es within each testing method, only one-wriabk from 
each method was used in the subsequent analysis: the 
number of ischemic episode&lay during ambulatory ECG 
monitoring. *he time to l-mm ST segment depression dating 
the exercise :est and the number of an&al eDisodesJweek. 
As previously repnted (II), each of the study mediitioos, 
when compared with placebo. had variable eftects on each 
measure of ischemia (fig. I). The greatest xduction in 
ischemic episodes was seen with sustained release D~~DI- 
loI, which reduced the tiquency of ischemic episodes from 
2.3 episodes/24 h with placebo to 1.0 episodeR4 h (p < 
O.OOOI). The effect of sttslained release diitiazem WBS more 
modest, reducing ischemic episodes to 1.9 episodes04 h 
(D = NSI. NiiediPine redtud ischemic episodes to 2.004 h 
6 = NS) (Fig. I&. 
Escrcise performance was a&ted to a much lesser 
extent than were ischemic episodes (Fig. IB). Fach of the 
medications increased the time to l-mm ST segment depres- 
sion by 3%. from 3.9 min with placebo to 4.0 min with each 
of the study medications (p < 0.001 for sustained release 
propa~olol, p < 0.01 for sustained release diltiazem and p = 
NS for nifedipine by the loa rank test). 
Anginal episodes were decreased (Fig. IC) from 2.3 
episodes/week with placebo to 1.3 episodes/week with both 
swained release propranolol and sustained release dilt- 
iazem (p = 0.001). and to 2.0 episodes/week with nifedipine 
(p = NS). 
Treatment responses compring different measure8 of iseh. 
emia. To determine whether drug treatment affected differ- 
ent measures of ischemia in a similar or different manner, 
individual patient responses to each agent were examined, 
comparing ischemic episodes/day during ambulatory ECG 
m&oring with the t&e to l-mm ST s&ment dep&ion 
during the exercise test and wth the number of anginal 
episodes/week. The results of the correlation analysis are 
presented in Table 4. The data showed a consistently low 
and statistically insignificant correlation coefficient obtained 
for each of the r&ions examined. The lack of significant 
correlation implies a lack of concordance between clinical 
response across different measures of &hernia. Thus. clin- 
ical effectiveness for a patient taking a certain drug, as 
detected by one measure of ischemia (for example, a reduc- 
tion in ambulatory ischemic episodes by sustained release 
propranolol) had little relation to that patient’s response to 
this drug for anginal episodes or exercise performance. 
Reqnmse to treatment for a given meawre of ischemia did 
not predict response to treatment for other measures of 
ischemia. 
Power calculations reveal that the study design provided 
a 0.96 probability of detecting correlations as high as 0.50. 
The range of correlations describing agreement between 
measures of &hernia (Tables 3 and 5) fell between 0.48 and 
0.93. Thus, ifany ofthe true correlations comparing different 
measures had been within this range, there would have been 
an extremely high probability of detecting them. 
Trealment resp0n.w campwing di&re;t drugs. To dcter- 
mine whether patients responded in asimilarmannerto each 
of the study medications, responses were compared for each 
patient for a given measure of &hernia. The results of the 
correlation analysis are shown in Table 5. The analysis 
showed ihat for both ambulatory ischemia and exercise 
perfammnce a strong correlation was found when different 
drugs were compared. Significant correlation indicates that 
patients who responded, for example. with an increase in the 
time to I-mm ST segment depression with an exercise test 
while being treated with one agent were likely lo have an 
increase in exercise time with another agent, although not 
necessarily of the same magnitude. When response to treat- 
ment for angina1 episodes was examined. patients were 
found to respond similarly to sustained release diltiazem and 
sustained release propranolol (r = 0.54. p < 0.001). hut 
response to either of these agents did not predict response to 
nifedipine (I = 0.29 and 0.16. respectively, p = NS). 
Figve 1. Response to each treatmest far SO patients. %rcent chang 
is expressed in comparison with placebo. A, Daily isckmic rpnodes 
as assessed by ambukuory eteclmcar*qwphr t*ECG) monitoriag 
8, Exercise test performance. C Anginat symptoms. Bat&d bars = 
sustained release propanolol: shaded kan = sustaircd releane dik. 
iazem: sdid bars = nifedipme. 
Discussion 
The primary conclusion from this study is that although 
eltd points assersing the magnitude of &hernia within each 
testing mde (ambulatory ECG monitoring. angina1 diary 
and exercise testing) were similar for each of the active 
lrealment regimens studied. there was no concordance of 
Tabk 4. Lack of Concordance of Patients’ Responses Between 
Measures of Ischemix Co&icienls of Comlatias (r values) 
for 50 Patients* 
end points assessing ischemia aenws testing modes. The 
assessment of ischemia and drug response by each testing 
method was independent of the assessment of ischemia using 
other testing methods. The implications of these observa- 
tions may be far-reaching: no single testing approach for the 
presence or severity of&hernia is clearly comprehensive or 
definitive. Current management decisions concerning pa- 
tients with stable coronary disease we often based on 
T&,&a 5. Concordance of Patients’ Responses lo A&r Drugs lor 
Each Meaoure d Isckmia: Coefficients of Correlation (r values1 
for 50 Patients 
““ginal symptoms and exercise test performance. If it is also 
imrmrtant to reduce or prevent asymptomatic ischemic epi. 
so&s that occur d”ring.daily activities, the” those episodes 
need to be soeci~?callv investiaated with ambulatory ECG 
monitoring. Altho”gh.other i&estig”tors have previously 
explored whether the presence of asymptomatic ischemia 
during ambulatory ECG monitoring can be predicted on the 
basis of other diagnostic information, such as angittal symp 
tams, exercise test performance or coronary anatomy, we 
know of no previous studies investigating whether the anti- 
ischemic therapeutic effect an ambulatory ischemia of dif- 
ferent treatment regimens can be predicted on the basis of 
the therapeutic effects on angina1 episodes and exercise test 
pelfonnance. 
Predictive value of exercise variables to identify the severity 
tdambvlatorv lschemia. Our observation that the frequency 
and severityof asymptomatic ambulatory ischemia b&e nb 
relation to anginal symptoms and exercise performance is 
consistent with a growing bcdy of evidence that ambulatory 
ischemic episodes, patticularly those that are asymptomalic. 
are a unique manifestation of stable coronary artery disease. 
The present study is in agreement with a recent study (9) in 
which exercise test variables had little relation to measures 
of ambulatory ischemia, as determined by 24-h ambulatory 
ECG recording. Similarly, Mody et al. (8) found no correla- 
tion between exercise time on a standard Bruce protocol and 
the cumulative duration of ambulatory ST segment depres- 
sion in a stud!, of 87 oatients with stable an8ina. 34 of whom 
hadevidencebf amh&ory ischemia. Patients with >6Omin 
of ST segment depressionl24 h were more likely IO have 
were coronary stenoses, but an absence of ambulatory ST 
segment depression failed to predict mild coronary disease. 
In contmst. several studies have shown that exercise test 
variables do predict the presence or severity of ambulatory 
ischemia. Cam&II et al. (71 studied 37 “atients with docu- 
memed coronary disease and found that 32 had positive 
findings on standard Bruce exercise tests and 21 of these 32 
also demonstrated ambulatory ischemia. No patient without 
exercise-induced ischemia had ambulatory ischemia. Simi- 
larly, in a study of I50 unselected patients with documented 
coronary disease, Mulcahy et al. (12) found that the time to 
I-mm ST segment depression a” a modified Bruce exercise 
test predicted the number of ambulatory ischemic episodes 
by mullivariatc analysis. A significant proportion (40%) of 
these patients had neither angina “or ambulatory &hernia; 
only one third hdd both. Deedwania and Carb”jal(6) studied 
86 patients with coronary disease who had a positive stan- 
dard Bruce exercise test: 39 of these 86 patients had ambu- 
latory ischemia and, for the group, as a hhole, a significant 
negative correlation existed between the time to I-mm ST 
segment depression and the cumulative duration of ambula- 
tory ische&a. One explanation for the difference between 
these findings, taken together, and the present sttldy, is that 
patient selection in the present study included only patients 
known to have the combination of a positive exercise test 
ischemia, thus constituting a relatively homogeneous group. 
When the subset of patients with both known angina and 
documented ambulatory ischemia is specitically examined, 
as in the present analysis and in the study of Benhorin et al. 
(9). the predictive power of the exercise test may become 
diminished. 
Another important possible explanation for the poor 
predictive value of the exercise test for ambulatory &hernia 
observed in our study is the nature of the physical stresses 
associated with the exercise test protocol employed. Similar 
to the observations by Mulcahy et al. (12) using a modified 
Bruce protocol, Panza and colleagues (13) observed a close 
correlation between the exercise duration to l-mm ST seg- 
ment depression on a more gradual National Institutes of 
Health exercise protocol and the number of ischemic epi- 
sodes (r = O&6), whereas the relation between time to 
&hernia using the more brisk standard Bruce protocol and 
freouencv ofambulatory &hernia was q”i!e weak (I = 0.35). 
Ex&ise~ protocols that increase physical stresses too 
abruptly may obscure subtle but impmtant discriminating 
features of the exercise perfommnce that are evident on less 
abruptly stressful pr0toe0ls. 
Diec”rdaltt &?cts d t&&mat on different meas”res or 
leehernia. Although characteristics of the exercise test per_ 
formance may fail to predict ambulatory ischemia in un- 
treated or placebo-treated patients (Table 2). a key question 
this study sought to answer specifically is whether anti-isch 
emit treatment will a&t exercise performance, ambulatory 
ischemia and angina in a similar manner. We found a 
discordance in anti-ischemic effect (Table 4) in that, for a 
given patient, a strong therapeutic response with respect to 
one measure of ischemia failed to predict a response with 
respect to the other measures of ischemia. 
In other studies that examined this question in part, 
different measures of ischemia were affected to diierent 
degrees. Ptishman et al. (14) compared diltiazem and “ifed- 
ipitte alone and in combination in 2ll patients and found that 
both drugs improved exercise tolerance similarly but that 
diltiazem produced greater reductions in anginaI symptoms 
and ambulatory ischemia thz” did “ifedipine. In a study of 
sustained release diltiazem, Theroux et al. (15) found that, 
compared with placebo, active treatment significantly re- 
duced ambulatory ischemia by SO%, increased exercise time 
by ” smaller mar& and had no eliecr on anginal symptoms. 
Shell and Dobson (16) sludied 20 “atieds in a comoarative 
trial of n&&pine an6 lrrmsderki nilr@ycerin aid found 
that nifedipine had minimal effect on ambulatory ischemia 
but increased exercise time, whereas nitroglycerin de- 
creased ambulatory ischemia but had no effect on exercise 
performance. Correlation analysis showed that exercise du- 
ration and cumulative duration of ambulatory ischemia were 
not related for nitroglycerin (r = 0.25), “ifedipitle (r = 0) or 
placebo (r = O.Ol), althou& aoginal symptoms were not 
measured. The present study is unique in that 11 a complete 
“ssessment of anti-ischemic efficacy was made in all pa- 
result, stable angina and documented frequent ambulatory tients, each of whom received placebo and three different 
agents at a maximally tolerated dose. and 2) correlation 
analysis was used to determine the interrelations among the 
various drugs for each patient 
hg twpom across masum of ischetnia. An additional 
finding of our study is that patients tended to respond similarly 
to different drugs within a given measure of ischemia (Table 5). 
Thus, although the absolute reduction in ambulatory ischemia 
was greater for sustained release propranolol than for sustained 
release dihiazem and negligible for nifedipine (Fig. I). re- 
sponses tended to be in the same direction, although they 
differed in magnitude, when the three drugs wctn compared 
(Table 5). Patients were also likely to have concordant rc- 
sponses to the three agents when exercise petformance was 
considered, but were less likely to have concordant responses 
when anginal symptoms were examined. Thus. when taken 
together with the preceding findings, our data indicate that 
patients were more likely to respond to a diierent drug with 
respect to the savne measure of ischemia trable 5) than they 
were to respond to the same dtug with respect to a different 
measure, of &hernia (Table 4). 
Limitations of the present study. Although the findings 
offer insight into the variability and interrelations of patients 
responses to anti-ischemic drugs, little can be concluded as 
to the mechanism of these differential effects or the mecha- 
nisms of ambulatory ischemia. Furthermore. although these 
patients had stable angina and typical features of a positive 
exercise test result with ST segment depression and angina, 
they were selected for inclusion in this study on the basis of 
presence of frequent episodes of asymptomatic ischemia on 
ambulatory ECG monitoring (23 episodesldayl. The appli- 
cabiity of our results in these patients to the group of 
patients with less frequent et+ des of ambulatory ischemia 
remains unknown. 
Cond&ms. Different measures of anti-ischemic efftcacy 
arc atfected differently in response to treatment and must be 
assessed independently. Treatment response with respect to 
attginal symptoms or exercise pcrfortttnnce cannot be used 
to infer efficacy of treatment aimed at ambulatory ischemia. 
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Univcrsily of Luth Florida. Tampa: Stephen P. Gtssser. MD, Priwipal 
tnvestigaor: Theresa Wizda-West. RN. Reseych Nurse. Sacred Heart 2nd 
References 
sat01 Nurse. University of Conncctwt. twmmgton: LJawd Ha@r. MU, 
Principal Investigator: Ellen McCabe. RN, Research Nurse. Hospital of tb 
Food Samaritan. Las Angeles: Thwas I,. Shook. MD, F’dncipal Inverti&? 
wr: Sandra Allen, h+SN. Rerearch Nurse 
w Cemdlwtt~ Cmter: Harvard Medical School, Bostim: Peter H. 
aml asymptom& epirades of ST segment depressian 
daily lik and during exercise. Circulation 1991:84:1~222. 
16. Shell WE. Bobson D. Dirsock!ion of exercise tokrma and lcial 
myacardial ixhemtc burden in chronic stabk angina prclaris. Am 3 
Caidiol 1990$&42-S. 
